CDH17 and cancer: Consistent with this, E-cadherin and N-cadherin were the dominant cadherin isoforms in less aggressive (RT4 and A549) and malignant (T24 and H1299) cancer cells, respectively (Figs S2, S5) (Elie-Caille et al., 2020; Mishra et al., 2018).